Related Experiment Video
Updated: Jul 30, 2026

Assessing Urinary Tract Junction Obstruction Defects by Methylene Blue Dye Injection
Published on: October 12, 2017
Role of urinary transforming growth factor-beta1 concentration in the diagnosis of upper urinary tract obstruction in
M T El-Sherbiny1, O M Mousa, A A Shokeir
1The Urology and Nephrology Center, Mansoura University, Mansoura, Eygpt.
Insights
Transforming growth factor-beta1 (TGF-beta1) in urine aids in diagnosing pediatric kidney obstruction. While levels decrease post-surgery, further study is needed to confirm this trend for TGF-beta1 in obstruction management.
Area of Science:
- Pediatric Nephrology
- Urology
- Biomarker Discovery
Background:
- Pelviureteral junction obstruction is a common cause of kidney damage in children.
- Accurate diagnosis and monitoring are crucial for preserving renal function.
- Noninvasive diagnostic tools are highly desirable for pediatric patients.
Purpose of the Study:
- To investigate the utility of transforming growth factor-beta1 (TGF-beta1) as a diagnostic marker for pediatric pelviureteral junction obstruction.
- To assess the changes in urinary TGF-beta1 levels following surgical correction of the obstruction.
Main Methods:
- Urinary TGF-beta1 levels were measured in children with confirmed pelviureteral junction obstruction and in a control group.
- Samples included renal pelvic and bladder urine.
- Bladder urine TGF-beta1 was re-evaluated 3 months after surgical intervention.
Main Results:
- Renal pelvic urine TGF-beta1 was significantly higher than bladder urine in obstructed kidneys.
- Bladder urine TGF-beta1 was significantly elevated in children with obstruction compared to controls.
- A trend towards decreased bladder urine TGF-beta1 was observed post-surgery, though not statistically significant.
- Urinary TGF-beta1 demonstrated 80% sensitivity, 82% specificity, and 81% accuracy for diagnosing obstruction.
Conclusions:
- Urinary TGF-beta1 serves as a valuable noninvasive biomarker for diagnosing upper urinary tract obstruction in children.
- Post-surgical follow-up shows a potential decrease in TGF-beta1 levels, suggesting its role in monitoring treatment response.
Purpose:
We evaluate the role of transforming growth factor-beta1 (TGF-beta1) in the diagnosis and followup of children with pelviureteral junction obstruction.
Materials And Methods:
TGF-beta1 concentration was measured in renal pelvic and bladder urine samples obtained from 15 children who underwent surgery for symptomatic unilateral pelviureteral junction obstruction. Bladder urine TGF-beta1 was also measured in 11 age matched patients with dilated nonobstructed kidneys as documented by nonobstructed washout curve and half-time drainage less than 10 minutes on diuretic renography. In the obstructed group bladder urine TGF-beta1 was measured 3 months after surgery.
Results:
In the obstructed group mean TGF-beta1 plus or minus SD in the renal pelvic urine was 285 +/- 191 pg./mg. creatinine, or 4-fold that of bladder urine (p >0.001). Mean bladder urine TGF-beta1 was 3-fold higher in patients with upper tract obstruction than in controls (68 +/- 59 versus 22 +/- 18 pg./mg. creatinine, p <0.003). Mean bladder TGF-beta1 3 months after surgery showed a trend towards a decrease, albeit still insignificant (68 +/- 59 versus 39 +/- 31 pg./mg. creatinine for preoperatively versus postoperatively, p <0.08). Using a bladder urine concentration of 29 pg./mg. creatinine as a cutoff between obstruction and no obstruction, TGF-beta1 was 80% sensitive, 82% specific and 81% accurate for the diagnosis of obstruction.
Conclusions:
Bladder urine TGF-beta1 is a useful noninvasive tool for diagnosis of upper urinary tract obstruction. At 3 months following corrective surgery there is a trend towards decrease in bladder TGF-beta1 concentration in comparison to the preoperative value.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Urinary Tract Infection I: Introduction
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Calculi III: Medical Management
Imaging Studies V: Intravenous Urography and Retrograde Pyelography

